Peritumoral Lidocaine Injection Before Breast Cancer Surgery Improves Outcomes
Breast cancer patients who receive a peritumoral injection of lidocaine immediately before surgery have better survival outcomes, a study suggests.
Breast cancer patients who receive a peritumoral injection of lidocaine immediately before surgery have better survival outcomes, a study suggests.
Radiotherapy after breast-conserving surgery can be omitted in women aged 65 years or older who have grade 1-2, ER-high breast cancer, as long as they receive 5 years of adjuvant endocrine therapy, according to researchers.